Literature DB >> 27259973

Accounting for heterogeneity in meta-analysis using a multiplicative model-an empirical study.

David Mawdsley1,2, Julian P T Higgins1, Alex J Sutton2, Keith R Abrams2.   

Abstract

In meta-analysis, the random-effects model is often used to account for heterogeneity. The model assumes that heterogeneity has an additive effect on the variance of effect sizes. An alternative model, which assumes multiplicative heterogeneity, has been little used in the medical statistics community, but is widely used by particle physicists. In this paper, we compare the two models using a random sample of 448 meta-analyses drawn from the Cochrane Database of Systematic Reviews. In general, differences in goodness of fit are modest. The multiplicative model tends to give results that are closer to the null, with a narrower confidence interval. Both approaches make different assumptions about the outcome of the meta-analysis. In our opinion, the selection of the more appropriate model will often be guided by whether the multiplicative model's assumption of a single effect size is plausible.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cochrane; fixed-effect; heterogeneity; meta-analysis; random-effects

Mesh:

Year:  2016        PMID: 27259973     DOI: 10.1002/jrsm.1216

Source DB:  PubMed          Journal:  Res Synth Methods        ISSN: 1759-2879            Impact factor:   5.273


  3 in total

1.  Graphical augmentations to sample-size-based funnel plot in meta-analysis.

Authors:  Lifeng Lin
Journal:  Res Synth Methods       Date:  2019-02-07       Impact factor: 5.273

2.  A Bayesian approach to assessing small-study effects in meta-analysis of a binary outcome with controlled false positive rate.

Authors:  Linyu Shi; Haitao Chu; Lifeng Lin
Journal:  Res Synth Methods       Date:  2020-06-17       Impact factor: 5.273

3.  Using structural equation modeling for network meta-analysis.

Authors:  Yu-Kang Tu; Yun-Chun Wu
Journal:  BMC Med Res Methodol       Date:  2017-07-14       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.